Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression

Keisuke Ieta, Eiki Ojima, Fumiaki Tanaka, Yoshito Nakamura, Naotsugu Haraguchi, Koshi Mimori, Hiroshi Inoue, Hiroyuki Kuwano, Masaki Mori

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

This study consisted of 2 aims: (i) to determine genes associated with hepatocellular carcinoma (HCC) by microarray analysis; and (ii) to evaluate the clinicopathological significance of human ubiquitin-conjugating enzyme E2C (Ube2c) found to be overexpressed in HCC from microarray analysis. Laser microdissection and cONA-microarray were performed to identify genes associated with HCC. We then focused on the Ube2c gene. Using real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR), Ube2c expression status and clinicopathological significance were studied in 65 clinical HCC samples. A number of genes upregulated in HCC cells compared to noncancerous liver cells were identified, one of which was the Ube2c gene. Ube2c gene expression in the cancer tissue was higher than in the corresponding noncancerous tissue in 62 of the 65 cases (95.4%, p < 0.01). Tumors with high Ube2c expression showed higher frequencies of tumor invasion to capsular formation (fc-inf), invasion to portal vein (vp) and tumor de-differentiation (p < 0.05). Patients with high Ube2c expression also showed significantly worse disease-free survival rates than those with low Ube2c expression (p < 0.01). In addition, Ube2c expression was found to be an independent prognostic factor for disease-free survival rate in multivariate analysis. We identified differentially expressed genes between HCC and normal liver tissues. Of those, the Ube2c gene appeared to be associated with HCC progression, and may be useful as a prognostic indicator for HCC patients.

Original languageEnglish
Pages (from-to)33-38
Number of pages6
JournalInternational Journal of Cancer
Volume121
Issue number1
DOIs
Publication statusPublished - Jul 1 2007

Fingerprint

Ubiquitin-Conjugating Enzymes
Hepatocellular Carcinoma
Gene Expression
Genes
Microarray Analysis
Disease-Free Survival
Neoplasms
Survival Rate
Microdissection
Liver
Portal Vein
Reverse Transcription
Lasers
Multivariate Analysis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. / Ieta, Keisuke; Ojima, Eiki; Tanaka, Fumiaki; Nakamura, Yoshito; Haraguchi, Naotsugu; Mimori, Koshi; Inoue, Hiroshi; Kuwano, Hiroyuki; Mori, Masaki.

In: International Journal of Cancer, Vol. 121, No. 1, 01.07.2007, p. 33-38.

Research output: Contribution to journalArticle

Ieta, Keisuke ; Ojima, Eiki ; Tanaka, Fumiaki ; Nakamura, Yoshito ; Haraguchi, Naotsugu ; Mimori, Koshi ; Inoue, Hiroshi ; Kuwano, Hiroyuki ; Mori, Masaki. / Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. In: International Journal of Cancer. 2007 ; Vol. 121, No. 1. pp. 33-38.
@article{af47db3a0bc74a3db8f2a373949954fa,
title = "Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression",
abstract = "This study consisted of 2 aims: (i) to determine genes associated with hepatocellular carcinoma (HCC) by microarray analysis; and (ii) to evaluate the clinicopathological significance of human ubiquitin-conjugating enzyme E2C (Ube2c) found to be overexpressed in HCC from microarray analysis. Laser microdissection and cONA-microarray were performed to identify genes associated with HCC. We then focused on the Ube2c gene. Using real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR), Ube2c expression status and clinicopathological significance were studied in 65 clinical HCC samples. A number of genes upregulated in HCC cells compared to noncancerous liver cells were identified, one of which was the Ube2c gene. Ube2c gene expression in the cancer tissue was higher than in the corresponding noncancerous tissue in 62 of the 65 cases (95.4{\%}, p < 0.01). Tumors with high Ube2c expression showed higher frequencies of tumor invasion to capsular formation (fc-inf), invasion to portal vein (vp) and tumor de-differentiation (p < 0.05). Patients with high Ube2c expression also showed significantly worse disease-free survival rates than those with low Ube2c expression (p < 0.01). In addition, Ube2c expression was found to be an independent prognostic factor for disease-free survival rate in multivariate analysis. We identified differentially expressed genes between HCC and normal liver tissues. Of those, the Ube2c gene appeared to be associated with HCC progression, and may be useful as a prognostic indicator for HCC patients.",
author = "Keisuke Ieta and Eiki Ojima and Fumiaki Tanaka and Yoshito Nakamura and Naotsugu Haraguchi and Koshi Mimori and Hiroshi Inoue and Hiroyuki Kuwano and Masaki Mori",
year = "2007",
month = "7",
day = "1",
doi = "10.1002/ijc.22605",
language = "English",
volume = "121",
pages = "33--38",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression

AU - Ieta, Keisuke

AU - Ojima, Eiki

AU - Tanaka, Fumiaki

AU - Nakamura, Yoshito

AU - Haraguchi, Naotsugu

AU - Mimori, Koshi

AU - Inoue, Hiroshi

AU - Kuwano, Hiroyuki

AU - Mori, Masaki

PY - 2007/7/1

Y1 - 2007/7/1

N2 - This study consisted of 2 aims: (i) to determine genes associated with hepatocellular carcinoma (HCC) by microarray analysis; and (ii) to evaluate the clinicopathological significance of human ubiquitin-conjugating enzyme E2C (Ube2c) found to be overexpressed in HCC from microarray analysis. Laser microdissection and cONA-microarray were performed to identify genes associated with HCC. We then focused on the Ube2c gene. Using real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR), Ube2c expression status and clinicopathological significance were studied in 65 clinical HCC samples. A number of genes upregulated in HCC cells compared to noncancerous liver cells were identified, one of which was the Ube2c gene. Ube2c gene expression in the cancer tissue was higher than in the corresponding noncancerous tissue in 62 of the 65 cases (95.4%, p < 0.01). Tumors with high Ube2c expression showed higher frequencies of tumor invasion to capsular formation (fc-inf), invasion to portal vein (vp) and tumor de-differentiation (p < 0.05). Patients with high Ube2c expression also showed significantly worse disease-free survival rates than those with low Ube2c expression (p < 0.01). In addition, Ube2c expression was found to be an independent prognostic factor for disease-free survival rate in multivariate analysis. We identified differentially expressed genes between HCC and normal liver tissues. Of those, the Ube2c gene appeared to be associated with HCC progression, and may be useful as a prognostic indicator for HCC patients.

AB - This study consisted of 2 aims: (i) to determine genes associated with hepatocellular carcinoma (HCC) by microarray analysis; and (ii) to evaluate the clinicopathological significance of human ubiquitin-conjugating enzyme E2C (Ube2c) found to be overexpressed in HCC from microarray analysis. Laser microdissection and cONA-microarray were performed to identify genes associated with HCC. We then focused on the Ube2c gene. Using real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR), Ube2c expression status and clinicopathological significance were studied in 65 clinical HCC samples. A number of genes upregulated in HCC cells compared to noncancerous liver cells were identified, one of which was the Ube2c gene. Ube2c gene expression in the cancer tissue was higher than in the corresponding noncancerous tissue in 62 of the 65 cases (95.4%, p < 0.01). Tumors with high Ube2c expression showed higher frequencies of tumor invasion to capsular formation (fc-inf), invasion to portal vein (vp) and tumor de-differentiation (p < 0.05). Patients with high Ube2c expression also showed significantly worse disease-free survival rates than those with low Ube2c expression (p < 0.01). In addition, Ube2c expression was found to be an independent prognostic factor for disease-free survival rate in multivariate analysis. We identified differentially expressed genes between HCC and normal liver tissues. Of those, the Ube2c gene appeared to be associated with HCC progression, and may be useful as a prognostic indicator for HCC patients.

UR - http://www.scopus.com/inward/record.url?scp=34248530332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248530332&partnerID=8YFLogxK

U2 - 10.1002/ijc.22605

DO - 10.1002/ijc.22605

M3 - Article

VL - 121

SP - 33

EP - 38

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -